Physician

Ajaz Ahamad Banka, MD

According to 2025 Medicare claims, Ajaz Banka, MD (NPI: 1811143233) practices endocrinology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is BEAUMONT MEDICAL GROUP- SPECIALTY SERVICES (NPI: 1578072906; TIN: 82-2784244) and primary practice location at 48025-5439.

Banka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 435 traditional Medicare patients, billed 1,427 HCPCS/CPT codes, and received $95,572 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 4,034 prescription claims across 631 beneficiaries totaling $1,778,367 in drug costs, led by Ozempic (Semaglutide). DME data shows 554 claims. Open Payments data shows 1 records totaling $13. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $40,554 to $95,572. Similarly, Part D prescription costs have moved sharply higher in recent years, from $392,525 to $1,778,367. For DME billing, reported payments moved sharply higher in recent years, from $7,279 to $155,277.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	391	756	$40,554
2016	435	845	$46,916
2017	424	818	$39,852
2018	308	1,154	$63,975
2019	522	1,757	$107,716
2020	549	1,767	$109,101
2021	574	1,903	$130,566
2022	486	1,337	$89,012
2023	480	1,617	$111,471
2024	435	1,427	$95,572

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	268	1,900	$392,525
2016	273	2,314	$530,495
2017	321	2,336	$579,991
2018	269	1,207	$467,556
2019	417	1,914	$856,836
2020	579	3,527	$1,431,303
2021	588	3,799	$1,610,380
2022	633	4,226	$2,075,617
2023	669	4,342	$2,466,647
2024	631	4,034	$1,778,367

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	92	393	$13,138
2016	102	414	$17,649
2017	99	392	$21,451
2018	63	122	$5,706
2019	69	245	$29,974
2020	183	611	$97,624
2021	165	708	$129,851
2022	199	798	$138,617
2023	185	802	$161,007
2024	149	554	$161,521

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	59	64	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	254	500	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	83	94	$65
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	98	437	$64
83036	Hemoglobin a1c level	152	271	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	268	14,608	$460,992
Jardiance	Empagliflozin	259	16,236	$299,173
Trulicity	Dulaglutide	82	4,172	$138,984
Mounjaro	Tirzepatide	95	3,390	$122,871
Tresiba Flextouch U-100	Insulin Degludec	56	3,914	$58,360

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	67	287	$116,388
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	32	$15,216
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	12	40	$8,929
E0784	External ambulatory infusion pump, insulin	Y	N/R	24	$8,268
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	26	$7,690

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$13	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ajaz Ahamad Banka, MD?

Tedicare shows public-source Medicare data for Ajaz Ahamad Banka, MD (NPI 1811143233), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajaz Ahamad Banka, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ajaz Ahamad Banka, MD?

Ajaz Ahamad Banka, MD is linked to BEAUMONT MEDICAL GROUP- SPECIALTY SERVICES (billing NPI 1578072906) in the available physician profile data.

Does Ajaz Ahamad Banka, MD have Open Payments data?

Ajaz Ahamad Banka, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.